NK Cells Market Report

Global and Region NK Cells Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：187
  • REPORT CODE：GMM936324
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of NK Cells market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of NK Cellsmarket, defines the market attractiveness level of NK Cells market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of NK Cells industry, describes the types of NK Cells market, the applications of major players and the market size, and deeply analyzes the current situation of the global NK Cells market and the development prospects and opportunities of NK Cells industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global NK Cells market in Chapter 13.

    By Player:

    • NantKwest Inc (USA)

    • Altor BioScience Corporation (USA)

    • Takeda Pharmaceutical (Japan)

    • NKT Therapeutics (USA)

    • Innate Pharma SA (France)

    • Affimed NV (Netherlands)

    • Bristol-Myers Squibb (USA)

    • Chipscreen Biosciences (China)

    • Sorrento Therapeutics Inc (USA)

    By Type:

    • Mogamulizumab

    • Lorvotuzumab Mertansine

    • Others

    By End-User:

    • Cancer

    • Cardiovascular Diseases

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 NK Cells Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 NK Cells Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 NK Cells Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 NK Cells Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise NK Cells Market Analysis and Outlook to 2022

    • 7.1 Global NK Cells Consumption (2017-2022)

    • 7.2 United States NK Cells Consumption (2017-2022)

    • 7.3 Europe NK Cells Consumption (2017-2022)

    • 7.4 China NK Cells Consumption (2017-2022)

    • 7.5 Japan NK Cells Consumption (2017-2022)

    • 7.6 India NK Cells Consumption (2017-2022)

    • 7.7 South Korea NK Cells Consumption (2017-2022)

    8 Region and Country-wise NK Cells Market Analysis and Outlook to 2028

    • 8.1 Global NK Cells Consumption Forecast (2022-2028)

    • 8.2 United States NK Cells Consumption Forecast (2022-2028)

    • 8.3 Europe NK Cells Consumption Forecast (2022-2028)

    • 8.4 China NK Cells Consumption Forecast (2022-2028)

    • 8.5 Japan NK Cells Consumption Forecast (2022-2028)

    • 8.6 India NK Cells Consumption Forecast (2022-2028)

    • 8.7 South Korea NK Cells Consumption Forecast (2022-2028)

    9 Global NK Cells Market Outlook by Types and Applications to 2022

    • 9.1 Global NK Cells Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Mogamulizumab Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Lorvotuzumab Mertansine Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global NK Cells Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global NK Cells Market Outlook by Types and Applications to 2028

    • 10.1 Global NK Cells Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Mogamulizumab Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Lorvotuzumab Mertansine Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global NK Cells Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global NK Cells Import and Export Analysis (Top 5 Countries)

    • 11.1 Global NK Cells Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global NK Cells Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 NK Cells Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global NK Cells Market Competitive Analysis

    • 14.1 NantKwest Inc (USA)

      • 14.1.1 NantKwest Inc (USA) Company Details

      • 14.1.2 NantKwest Inc (USA) NK Cells Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 NantKwest Inc (USA) NK Cells Product and Service

    • 14.2 Altor BioScience Corporation (USA)

      • 14.2.1 Altor BioScience Corporation (USA) Company Details

      • 14.2.2 Altor BioScience Corporation (USA) NK Cells Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Altor BioScience Corporation (USA) NK Cells Product and Service

    • 14.3 Takeda Pharmaceutical (Japan)

      • 14.3.1 Takeda Pharmaceutical (Japan) Company Details

      • 14.3.2 Takeda Pharmaceutical (Japan) NK Cells Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Takeda Pharmaceutical (Japan) NK Cells Product and Service

    • 14.4 NKT Therapeutics (USA)

      • 14.4.1 NKT Therapeutics (USA) Company Details

      • 14.4.2 NKT Therapeutics (USA) NK Cells Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 NKT Therapeutics (USA) NK Cells Product and Service

    • 14.5 Innate Pharma SA (France)

      • 14.5.1 Innate Pharma SA (France) Company Details

      • 14.5.2 Innate Pharma SA (France) NK Cells Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Innate Pharma SA (France) NK Cells Product and Service

    • 14.6 Affimed NV (Netherlands)

      • 14.6.1 Affimed NV (Netherlands) Company Details

      • 14.6.2 Affimed NV (Netherlands) NK Cells Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Affimed NV (Netherlands) NK Cells Product and Service

    • 14.7 Bristol-Myers Squibb (USA)

      • 14.7.1 Bristol-Myers Squibb (USA) Company Details

      • 14.7.2 Bristol-Myers Squibb (USA) NK Cells Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Bristol-Myers Squibb (USA) NK Cells Product and Service

    • 14.8 Chipscreen Biosciences (China)

      • 14.8.1 Chipscreen Biosciences (China) Company Details

      • 14.8.2 Chipscreen Biosciences (China) NK Cells Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Chipscreen Biosciences (China) NK Cells Product and Service

    • 14.9 Sorrento Therapeutics Inc (USA)

      • 14.9.1 Sorrento Therapeutics Inc (USA) Company Details

      • 14.9.2 Sorrento Therapeutics Inc (USA) NK Cells Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Sorrento Therapeutics Inc (USA) NK Cells Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of NK Cells

    • Figure NK Cells Picture

    • Table Global NK Cells Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global NK Cells Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global NK Cells Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global NK Cells Consumption by Country (2017-2022)

    • Figure United States NK Cells Consumption and Growth Rate (2017-2022)

    • Table Europe NK Cells Consumption and Growth Rate (2017-2022)

    • Figure China NK Cells Consumption and Growth Rate (2017-2022)

    • Figure Japan NK Cells Consumption and Growth Rate (2017-2022)

    • Figure India NK Cells Consumption and Growth Rate (2017-2022)

    • Figure South Korea NK Cells Consumption and Growth Rate (2017-2022)

    • Figure Global NK Cells Consumption Forecast by Country (2022-2028)

    • Figure United States NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure China NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure India NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Mogamulizumab Consumption and Growth Rate (2017-2022)

    • Figure Global Lorvotuzumab Mertansine Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Mogamulizumab Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lorvotuzumab Mertansine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global NK Cells Import by Region (Top 5 Countries) (2017-2028)

    • Table Global NK Cells Export by Region (Top 5 Countries) (2017-2028)

    • Table NantKwest Inc (USA) (Foundation Year, Company Profile and etc.)

    • Table NantKwest Inc (USA) NK Cells Sales, Price, Value and Gross Profit (2017-2022)

    • Table NantKwest Inc (USA) NK Cells Product and Service

    • Table Altor BioScience Corporation (USA) (Foundation Year, Company Profile and etc.)

    • Table Altor BioScience Corporation (USA) NK Cells Sales, Price, Value and Gross Profit (2017-2022)

    • Table Altor BioScience Corporation (USA) NK Cells Product and Service

    • Table Takeda Pharmaceutical (Japan) (Foundation Year, Company Profile and etc.)

    • Table Takeda Pharmaceutical (Japan) NK Cells Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takeda Pharmaceutical (Japan) NK Cells Product and Service

    • Table NKT Therapeutics (USA) (Foundation Year, Company Profile and etc.)

    • Table NKT Therapeutics (USA) NK Cells Sales, Price, Value and Gross Profit (2017-2022)

    • Table NKT Therapeutics (USA) NK Cells Product and Service

    • Table Innate Pharma SA (France) (Foundation Year, Company Profile and etc.)

    • Table Innate Pharma SA (France) NK Cells Sales, Price, Value and Gross Profit (2017-2022)

    • Table Innate Pharma SA (France) NK Cells Product and Service

    • Table Affimed NV (Netherlands) (Foundation Year, Company Profile and etc.)

    • Table Affimed NV (Netherlands) NK Cells Sales, Price, Value and Gross Profit (2017-2022)

    • Table Affimed NV (Netherlands) NK Cells Product and Service

    • Table Bristol-Myers Squibb (USA) (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb (USA) NK Cells Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb (USA) NK Cells Product and Service

    • Table Chipscreen Biosciences (China) (Foundation Year, Company Profile and etc.)

    • Table Chipscreen Biosciences (China) NK Cells Sales, Price, Value and Gross Profit (2017-2022)

    • Table Chipscreen Biosciences (China) NK Cells Product and Service

    • Table Sorrento Therapeutics Inc (USA) (Foundation Year, Company Profile and etc.)

    • Table Sorrento Therapeutics Inc (USA) NK Cells Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sorrento Therapeutics Inc (USA) NK Cells Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US